ISSN 2147-9720 | E-ISSN 2148-4279
Case Report
Presentation of three cases followed up with a diagnosis of Felty syndrome
(Eur J Rheumatol 2014; 1: 120-122)
DOI: 10.5152/eurjrheumatol.2014.026
Methorexate therapy in a patient with rheumatoid arthritis complicated by idiopathic thrombocytopenic purpura
(Eur J Rheumatol 2015; 2: 39-40)
DOI: 10.5152/eurjrheumatol.2014.14065
Hemophagocytic lymphohistiocytosis after certolizumab treatment in a patient with rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 203-205)
DOI: 10.5152/eurjrheum.2018.17108
Can rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?
(Eur J Rheumatol 2017; 4: 57-58)
DOI: 10.5152/eurjrheum.2017.160058
Rheumatoid arthritis and tabetic arthropathy: physiopathological link or simple association?
(Eur J Rheumatol 2016; 3: 41-43)
DOI: 10.5152/eurjrheum.2015.0006
Hydroxychloroquine-induced agranulocytosis in a patient with long-term rheumatoid arthritis
(Eur J Rheumatol 2016; 3: 91-92)
DOI: 10.5152/eurjrheum.2015.0028
Severe candida laryngitis in a patient with rheumatoid arthritis treated with adalimumab
(Eur J Rheumatol 2014; 1: 167-169)
DOI: 10.5152/eurjrheumatol.2014.140001
Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature
(Eur J Rheumatol 2017; 4: 139-141)
DOI: 10.5152/eurjrheum.2017.16066
Cavitary pulmonary nodules in rheumatoid arthritis; case reports and review of the literature
(Eur J Rheumatol 2018; 5: 65-68)
DOI: 10.5152/eurjrheum.2017.16106
Original Article
Muscle loss following a single high-dose intramuscular injection of corticosteroids to treat disease flare in patients with rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 160-164)
DOI: 10.5152/eurjrheum.2018.17148
Is rheumatoid arthritis an innocent bystander in female reproductive problems? A comparative study of fertility in Nigerian women with and without rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 179-183)
DOI: 10.5152/eurjrheum.2018.17180
Risk factor assessment of rheumatoid arthritis in North Kerala
(Eur J Rheumatol 2018; 5: 184-190)
DOI: 10.5152/eurjrheum.2018.17111
Relationship between asymmetric dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis
(Eur J Rheumatol 2016; 3: 106-108)
DOI: 10.5152/eurjrheum.2016.15096
Humor in systemic lupus erythematosus
(Eur J Rheumatol 2015; 2: 5-9)
DOI: 10.5152/eurjrheumatol.2015.0070
Prevalence of the metabolic syndrome in rheumatoid arthritis
(Eur J Rheumatol 2014; 1: 1-4)
DOI: 10.5152/eurjrheum.2014.001
Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: A multicenter countrywide study
(Eur J Rheumatol 2014; 1: 51-54)
DOI: 10.5152/eurjrheumatol.2014.018
Mental health status can reflect disease activity in rheumatoid arthritis
(Eur J Rheumatol 2014; 1: 55-57)
DOI: 10.5152/eurjrheumatol.2014.020
The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study
(Eur J Rheumatol 2014; 1: 67-71)
DOI: 10.5152/eurjrheumatol.2014.022
The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus
(Eur J Rheumatol 2014; 1: 92-95)
DOI: 10.5152/eurjrheumatol.2014.032
Sarcopenia in women with rheumatoid arthritis
(Eur J Rheumatol 2015; 2: 57-61)
DOI: 10.5152/eurjrheum.2015.0038
Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers
(Eur J Rheumatol 2015; 2: 62-65)
DOI: 10.5152/eurjrheum.2015.0101
Serum hepcidin level and rheumatoid arthritis disease activity
(Eur J Rheumatol 2019; 6: 76-80)
DOI: 10.5152/eurjrheum.2018.18114
Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis
(Eur J Rheumatol 2019; 6: 81-84)
DOI: 10.5152/eurjrheum.2019.18109
Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice
(Eur J Rheumatol 2019; 6: 136-141)
DOI: 10.5152/eurjrheum.2019.18195
Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning
(Eur J Rheumatol 2016; 3: 44-49)
DOI: 10.5152/eurjrheum.2015.0055
Changes in sirtuin 2 and sirtuin 3 mRNA expressions in rheumatoid arthritis
(Eur J Rheumatol 2017; 4: 83-86)
DOI: 10.5152/eurjrheum.2017.16056
Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
(Eur J Rheumatol 2018; 5: 85-91)
DOI: 10.5152/eurjrheum.2018.17113
Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance
(Eur J Rheumatol 2014; 1: 135-139)
DOI: 10.5152/eurjrheumatol.2014.140046
Surgery for lumbar spinal stenosis in patients with rheumatoid arthritis: A multicenter observational study
(Eur J Rheumatol 2016; 3: 56-60)
DOI: 10.5152/eurjrheum.2016.15070
Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy
(Eur J Rheumatol 2019; 6: 19-22)
DOI: 10.5152/eurjrheum.2018.18096
A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis
(Eur J Rheumatol 2019; 6: 23-28)
DOI: 10.5152/eurjrheum.2018.18078
Evaluating disease activity in patients with ankylosing spondylitis and rheumatoid arthritis using 99mtc-glucosamine
(Eur J Rheumatol 2016; 3: 65-72)
DOI: 10.5152/eurjrheum.2016.15074
Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone
(Eur J Rheumatol 2014; 1: 147-149)
DOI: 10.5152/eurjrheumatol.2014.140074
Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?
(Eur J Rheumatol 2018; 5: 22-26)
DOI: 10.5152/eurjrheum.2018.17021
Case series: Monoarticular rheumatoid arthritis
(Eur J Rheumatol 2017; 4: 264-267)
DOI: 10.5152/eurjrheum.2017.17011
A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment
(Eur J Rheumatol 2018; 5: 111-114)
DOI: 10.5152/eurjrheum.2018.17147
Relationship between bone mineral density and anti-citrullinated protein antibody and rheumatoid factor in patients with rheumatoid arthritis
(Eur J Rheumatol 2019; 6: 29-33)
DOI: 10.5152/eurjrheum.2018.18099
Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis
(Eur J Rheumatol 2017; 4: 40-45)
DOI: 10.5152/eurjrheum.2017.16052
The new ACR/EULAR criteria for rheumatoid arthritis can identify patients with same disease activity but less damage by ultrasound
(Eur J Rheumatol 2017; 4: 118-121)
DOI: 10.5152/eurjrheum.2017.160091
Rheumatoid Arthritis: Are psychological factors effective in disease flare?
(Eur J Rheumatol 2017; 4: 127-132)
DOI: 10.5152/eurjrheum.2017.16100
Invited Review
Pre-rheumatoid arthritis and its prevention
(Eur J Rheumatol 2017; 4: 161-165)
DOI: 10.5152/eurjrheum.2017.16006
Literature Review
Management of the temporomandibular joint in inflammatory arthritis: Involvement of surgical procedures
(Eur J Rheumatol 2017; 4: 151-156)
DOI: 10.5152/eurjrheum.2016.035
Giant cell arteritis, polymyalgia rheumatica, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?
(Eur J Rheumatol 2017; 4: 157-160)
DOI: 10.5152/eurjrheum.2016.039
Key Words
Author’s Corner
AVES | Copyright © 2019 Medical Research and Education Association | Latest Update: 24.07.2019